Human IgG1 Kappa Isotype Control LALAPG - VcMMAE DAR4

In stock
Only %1 left
SKU
ICH2254LALAPG-VM4
Add to Compare
$1,220.00 - $4,355.00

Human IgG1 Kappa Isotype Control LALAPG - VcMMAE DAR4

Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Species Reactivity
Human
Target
Hen Egg Lysozyme
Isotype
Human IgG1
Buffer
ICH3001
Shipping Conditions
Blue ice
Background
Pairing Fc silencing with a defined payload, this control supports clean interpretation of effector-null ADC experiments. The LALA-PG-mutated human IgG1 kappa isotype control recognizes hen egg lysozyme, an antigen with no mammalian counterpart, giving no specific binding and serving as a negative control. Conjugated with MMAE through a valine-citrulline linker at a drug-to-antibody ratio of 4 (DAR4), it lets researchers separate payload and Fc-silencing contributions from target engagement when establishing background and gating in functional studies. Offered for research use only in a low-endotoxin format suitable for in vivo use, it is manufactured in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives. 0.2 μM filtered
Storage
The product should be stored in the original stock concentration at 4°C. Avoid freeze / thaw cycles.
Use
Research Use Only. Not for Therapeutic or Diagnostic Use
Write Your Own Review
You're reviewing:Human IgG1 Kappa Isotype Control LALAPG - VcMMAE DAR4
Your Rating
Back to Top